Japan Tissue Engineering Co., Ltd. (TYO:7774)
502.00
+14.00 (2.87%)
Sep 12, 2025, 3:30 PM JST
Japan Tissue Engineering Revenue
Japan Tissue Engineering had revenue of 426.37M JPY in the quarter ending June 30, 2025, a decrease of -3.60%. This brings the company's revenue in the last twelve months to 2.44B, up 6.34% year-over-year. In the fiscal year ending March 31, 2025, Japan Tissue Engineering had annual revenue of 2.46B, down -2.35%.
Revenue (ttm)
2.44B
Revenue Growth
+6.34%
P/S Ratio
8.36
Revenue / Employee
11.96M
Employees
204
Market Cap
20.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 2.46B | -59.00M | -2.35% |
Mar 31, 2024 | 2.51B | 482.00M | 23.72% |
Mar 31, 2023 | 2.03B | -71.00M | -3.38% |
Mar 31, 2022 | 2.10B | -154.00M | -6.82% |
Mar 31, 2021 | 2.26B | -52.00M | -2.25% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |